Ahren Innovation Capital
Ahren is a deep tech and deep science investment firm set up by Alice Newcombe-Ellis alongside co-Founding Science Partners. Together, these Founders created companies and/or technologies that are today valued in excess of $100BN combined. The firm was established from first principles with a mission to be disruptive as an investment institution, with a new model – genuine partnership between the creators of deep technology and deep science, and commercially active, long-term capital, to harness tremendous global talent and build and exponentially accelerate the next generation of great enterprises. Ahren’s Portfolio companies include AI21 Labs, Graphcore, Zapata Computing, ZOE, Phaidra, Heirloom Carbon, and Bicycle Therapeutics among others. Ahren has >$800M AUM and has team members in Cambridge (UK), London, and Boston.
Ahren Innovation Capital focuses on deep tech and deep science, investing in AI, machine learning, quantum computing, and biotech. While based in the UK, it is a high-growth venture/growth firm rather than a traditional search fund.
Greater London, England, United Kingdom
Venture Capital and Private Equity Principals
venture capital, growth equity
deep tech, deep science, AI, biotech
Done
Prospects
No prospects linked to this account.
Outreach History
Outreach sequencing tables are not yet in Supabase.